Uromigos Live-Bladder Cancer
Listen to the podcast format of the peri-operative therapy in bladder cancer panel from Uromigos Live 2024. Listen to the podcast format of the panel on on emerging ADC data in bladder cancer from Uromigos Live 2024. Petros Grivas, MD, PhD, Director of UW Medicine's GU Cancers Program, talks about the efficacy of sacituzumab govitecan. Shilpa Gupta, MD discusses maintenance therapy for bladder cancer, including the current standard of care and ongoing trials. Thomas Powles, MBBS, MRCP, MD gives an overview of highlights from The Uromigos: Live & Unplugged bladder cancer session. Matthew Galsky, MD gives insight on adjuvant nivolumab trials, including use in unselected patients and overall survival. Kala Sridhar talks about bladder-sparing treatments for urothelial carcinoma and how patient populations are shifting. Jonathan Rosenberg, MD talks about the development of enfortumab vedotin, including monotherapy info and combination data. The bladder cancer buzzer round from The Uromigos: Live & Unplugged.